74 related articles for article (PubMed ID: 713826)
21. In vivo and in vitro evaluation of immune response of hamsters to immunization and transplants of autochthonous reticulum cell sarcoma.
Gerber MJ; Brown ER
Cancer Res; 1973 Nov; 33(11):3029-35. PubMed ID: 4583977
[No Abstract] [Full Text] [Related]
22. Effects of antigenic competition on immune responses to tumors.
Glasgow AH; Badger AM
Ann N Y Acad Sci; 1976; 276():496-501. PubMed ID: 1071974
[No Abstract] [Full Text] [Related]
23. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
Klein E; Klein G
Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
[No Abstract] [Full Text] [Related]
24. Immune capacity and response to antigenic tumors.
Risdall RJ; Aust JC; McKhann CF
Cancer Res; 1973 Sep; 33(9):2078-85. PubMed ID: 4146855
[No Abstract] [Full Text] [Related]
25. [Tumor radiotherapy and immune status of the host in an allogenic system].
Deneufbourg JM
Bull Cancer; 1972; 59(1):61-76. PubMed ID: 4117668
[No Abstract] [Full Text] [Related]
26. Macrophage accumulation in transplanted tumors is not dependent on host immune responsiveness or presence of tumor-associated rejection antigens.
Evans R; Eidlen DM
J Reticuloendothel Soc; 1981 Nov; 30(5):425-37. PubMed ID: 7321000
[No Abstract] [Full Text] [Related]
27. [Relationship between tumor antigens and histocompatibility antigens at the cell membrane].
Meyer G; Berebbi M; Oth D
Bull Cancer; 1976; 63(1):111-21. PubMed ID: 791395
[TBL] [Abstract][Full Text] [Related]
28. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
Fujimoto S; Greene MI; Sehon AH
J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
[TBL] [Abstract][Full Text] [Related]
29. Tumor rejection and immunotherapy studies with simian virus 40-induced tumors.
Blakeslee JR; von Muenchhausen W; Cox HR
J Med; 1973; 4(4):233-47. PubMed ID: 4358481
[No Abstract] [Full Text] [Related]
30. Studies on immunity to autochthonous mouse tumors.
Hellström I; Hellström KE; Pierce GE; Fefer A
Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
[No Abstract] [Full Text] [Related]
31. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines.
Edelman AS; Xue B; Sanchez P; Thorbecke GJ
J Immunol; 1985 Sep; 135(3):2206-12. PubMed ID: 3926898
[TBL] [Abstract][Full Text] [Related]
32. [Antigenic systems of tumors and leukemias induced by oncornaviruses].
Levy JP; Kourilsky FM
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):741-53. PubMed ID: 4340545
[No Abstract] [Full Text] [Related]
33. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.
Fujimoto S; Greene MI; Sehon AH
J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955
[TBL] [Abstract][Full Text] [Related]
34. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
35. Immunogenic properties of soluble cytosol fractions on Meth A sarcoma cells.
DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
Cancer Res; 1980 Nov; 40(11):4204-8. PubMed ID: 7471061
[TBL] [Abstract][Full Text] [Related]
36. Effect of regional lymphadenectomy on development of concomitant immunity.
Soloway MS; Pendergrast WJ; Myers GH
Surg Forum; 1972; 23(0):101-2. PubMed ID: 4671039
[No Abstract] [Full Text] [Related]
37. RT1.C and rat bone marrow transplantation.
Klempnauer J; Marquarding E
Transplant Proc; 1989 Apr; 21(2):3292-3. PubMed ID: 2652816
[No Abstract] [Full Text] [Related]
38. Immune response to an allogeneic progressively growing solid tumor.
Eggers AE
Cancer Res; 1976 Jun; 36(6):2085-9. PubMed ID: 773534
[TBL] [Abstract][Full Text] [Related]
39. Proceedings: Escape from immune destruction by the host through shedding of surface antigens: is this a characteristic shared by malignant and embryonic cells?
Alexander P
Cancer Res; 1974 Aug; 34(8):2077-82. PubMed ID: 4858342
[No Abstract] [Full Text] [Related]
40. Abrogation of tumorigenicity by MHC class II antigen expression requires the cytoplasmic domain of the class II molecule.
Ostrand-Rosenberg S; Roby CA; Clements VK
J Immunol; 1991 Oct; 147(7):2419-22. PubMed ID: 1918972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
